GSA Capital Partners’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

GSA Capital Partners’s Portfolio HPTX Stock Details HPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-21,196	Closed	-$973K	–	2407
2015 Q1	$973K	Buy	21,196 +8,297	+64%	+$248K	0.04%	883
2014 Q4	$310K	Buy	+12,899	New	+$291K	0.02%	1241
2014 Q1	–	Sell	-20,494	Closed	-$414K	–	1990
2013 Q4	$414K	Buy	20,494 +9,499	+86%	+$224K	0.03%	984
2013 Q3	$287K	Buy	+10,995	New	+$275K	0.02%	1171

GSA Capital Partners's HPTX Position: Q2 2015 in Review

GSA Capital Partners sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 21,196 shares — an estimated $973K sold.

GSA Capital Partners first reported a position in HPTX in Q3 2013 and held it in 4 quarters. The position peaked at $973K in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

GSA Capital Partners reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
GSA Capital Partners sold 21,196 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $973K.
GSA Capital Partners first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q3 2013 and held it in 4 quarters.
GSA Capital Partners's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $973K in Q1 2015.
0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on GSA Capital Partners's 13F filing for Q2 2015, filed 14 Aug 2015.